Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|November 13, 2003
Linearized and truncated microcystin analogues as inhibitors of protein phosphatases 1 and 2ABrian M Gulledge, James B Aggen, A Richard Chamberlin
Chemmedchem|December 10, 2020
Tautomycetin Synthetic Analogues: Selective Inhibitors of Protein Phosphatase IZachary R Woydziak, A John Yucel, A Richard Chamberlin
Bioorganic & Medicinal Chemistry Letters|February 4, 2006
Design, synthesis, and biological evaluation of a scaffold for iGluR ligands based on the structure of (-)-dysiherbaineJamie L Cohen, Agenor Limon, Ricardo Miledi, et al.
Journal of Medicinal Chemistry|September 16, 2015
Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore ModelParminder Kaur, A Richard Chamberlin, Thomas L Poulos, et al.
Bioorganic & Medicinal Chemistry|March 10, 2006
Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integraseTrevor T Charvat, Deborah J Lee, W Edward Robinson, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activityMatthew E Hart, A Richard Chamberlin, Cecilia Walkom, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2003
Microcystin analogues comprised only of Adda and a single additional amino acid retain moderate activity as PP1/PP2A inhibitorsBrian M Gulledge, James B Aggen, Hugo Eng, et al.
The Journal of Organic Chemistry|February 5, 2009
Stereoselective synthesis of chiral IBR2 analoguesXiao-Long Qiu, Jiewen Zhu, Guikai Wu, et al.
Biophysical Journal|January 27, 2023
DOTAP: Structure, hydration, and the counterion effectMihaela Mihailescu, David L Worcester, Christopher L Carroll, et al.
Pageof 4